Jump to main content
Jump to site search

Issue 2, 2016
Previous Article Next Article

Immune response to functionalized mesoporous silica nanoparticles for targeted drug delivery

Author affiliations

Abstract

Multifunctional mesoporous silica nanoparticles (MSN) have attracted substantial attention with regard to their high potential for targeted drug delivery. For future clinical applications it is crucial to address safety concerns and understand the potential immunotoxicity of these nanoparticles. In this study, we assess the biocompatibility and functionality of multifunctional MSN in freshly isolated, primary murine immune cells. We show that the functionalized silica nanoparticles are rapidly and efficiently taken up into the endosomal compartment by specialized antigen-presenting cells such as dendritic cells. The silica nanoparticles showed a favorable toxicity profile and did not affect the viability of primary immune cells from the spleen in relevant concentrations. Cargo-free MSN induced only very low immune responses in primary cells as determined by surface expression of activation markers and release of pro-inflammatory cytokines such as Interleukin-6, -12 and -1β. In contrast, when surface-functionalized MSN with a pH-responsive polymer capping were loaded with an immune-activating drug, the synthetic Toll-like receptor 7 agonist R848, a strong immune response was provoked. We thus demonstrate that MSN represent an efficient drug delivery vehicle to primary immune cells that is both non-toxic and non-inflammagenic, which is a prerequisite for the use of these particles in biomedical applications.

Graphical abstract: Immune response to functionalized mesoporous silica nanoparticles for targeted drug delivery

Back to tab navigation

Supplementary files

Publication details

The article was received on 07 Sep 2015, accepted on 01 Dec 2015 and first published on 11 Dec 2015


Article type: Paper
DOI: 10.1039/C5NR06122A
Citation: Nanoscale, 2016,8, 938-948
  • Open access: Creative Commons BY-NC license
  •   Request permissions

    Immune response to functionalized mesoporous silica nanoparticles for targeted drug delivery

    S. Heidegger, D. Gößl, A. Schmidt, S. Niedermayer, C. Argyo, S. Endres, T. Bein and C. Bourquin, Nanoscale, 2016, 8, 938
    DOI: 10.1039/C5NR06122A

    This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. Material from this article can be used in other publications provided that the correct acknowledgement is given with the reproduced material and it is not used for commercial purposes.

    Reproduced material should be attributed as follows:

    • For reproduction of material from NJC:
      [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the Centre National de la Recherche Scientifique (CNRS) and the RSC.
    • For reproduction of material from PCCP:
      [Original citation] - Published by the PCCP Owner Societies.
    • For reproduction of material from PPS:
      [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the European Society for Photobiology, the European Photochemistry Association, and RSC.
    • For reproduction of material from all other RSC journals:
      [Original citation] - Published by The Royal Society of Chemistry.

    Information about reproducing material from RSC articles with different licences is available on our Permission Requests page.

Search articles by author

Spotlight

Advertisements